FdaApplication
ANDA 215516
Identifiers
- fda_app_no: ANDA215516
Properties
| Property | Value |
|---|---|
| applicant_name | GLAND PHARMA LTD |
| application_type | ANDA |
| approval_date | 2022-05-24 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE;INJECTION |
| CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | EQ 2MG BASE/ML | INJECTABLE;INJECTION |
| CISATRACURIUM BESYLATE | CISATRACURIUM BESYLATE | EQ 10MG BASE/ML | INJECTABLE;INJECTION |
3 products